See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2015_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 164,951,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,150,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,568,000 |
| 3 | remainder_Assets | 1,811,000 |
| 4 | LiabilitiesCurrent | 35,192,000 |
| 5 | LiabilitiesNoncurrent | 1,022,000 |
| 6 | remainder_Liabilities | 3,252,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,533,000 |
| 9 | ResearchAndDevelopmentExpense | 41,046,000 |
| 10 | remainder_Expenses | 40,000 |
| 11 | remainder_Revenues | 8,057,000 |
| 12 | remainder_NetIncome | -12,118,000 |
| 13 | remainder_ComprehensiveNetIncome | -181,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 171,480,000 |
| 1 | Liabilities | 39,466,000 |
| 2 | Expenses | 52,619,000 |
| 3 | Revenues | 8,057,000 |
| 4 | StockholdersEquity | 132,014,000 |
| 5 | NetIncome | -56,680,000 |
| 6 | ComprehensiveNetIncome | -56,770,500 |
| 7 | BaseVar | 141,960,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.19 |
| 9 | EconomicCapitalRatio | 3.15 |